Lessons from Cost-Effectiveness Research for United States Public Health Policy
- 1 April 2007
- journal article
- review article
- Published by Annual Reviews in Annual Review of Public Health
- Vol. 28 (1), 365-391
- https://doi.org/10.1146/annurev.publhealth.28.021406.144046
Abstract
The application of cost-effectiveness analysis to health care has been the subject of previous reviews. We address the use of economic evaluation methods in public health, including case studies of population-level policies, e.g., environmental regulations, injury prevention, tobacco control, folic acid fortification, and blood product safety, and the public health promotion of clinical preventive services, e.g., newborn screening, cancer screening, and childhood immunizations. We review the methods used in cost-effectiveness analysis, the implications for cost-effectiveness findings, and the extent to which economic studies have influenced policy and program decisions. We discuss reasons for the relatively limited impact to date of economic evaluation in public health. Finally, we address the vexing question of how to decide which interventions are cost effective and worthy of funding. Policy makers have funded certain interventions with rather high cost-effectiveness ratios, notably nucleic acid testing for blood product safety. Cost-effectiveness estimates are a decision aid, not a decision rule.Keywords
This publication has 112 references indexed in Scilit:
- The Business Case for Preconception Care: Methods and IssuesMaternal and Child Health Journal, 2006
- Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap TestsObstetrics & Gynecology, 2006
- Cost-Effectiveness of Alternative Blood-Screening Strategies for West Nile Virus in the United StatesPLoS Medicine, 2006
- Does newborn screening save money? The difference between cost-effective and cost-saving interventionsThe Journal of Pediatrics, 2005
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- Neonatal screening for sickle cell disease: A cost-effectiveness analysisThe Journal of Pediatrics, 1991
- Prophylaxis with Oral Penicillin in Children with Sickle Cell AnemiaNew England Journal of Medicine, 1986
- Use and Misuse of the Term “Cost Effective” in MedicineNew England Journal of Medicine, 1986